Jeff June – Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
Jeff June, Innovation Advisor at Early Stage Digital Health, MedTech, Venture Capital, and Accelerator Programs, posted on LinkedIn:
”I just published an article (click link or image below) about a grant program to advance your start up in spatial biology.
I’m also including my abstract (also in the article link) for leveraging a Miltenyi Biotec MACS Imaging Grant to apply spatial biology in stroke care.
I hope people in my network will apply for this opportunity (looking at you University Lab Partners, BioTools Innovator, MedTech Innovator, National Science Foundation (NSF), Gates Foundation).
I encourage anyone exploring spatial biology, imaging, or molecular diagnostics to apply before October 31st.
For me, this was more than an application – it’s part of how we’re redefining stroke diagnostics at Ischemia Care. Our RNA-based assay (ISCDx) has already shown that blood can reveal the mechanism of stroke, but this next step uses spatial biology to see those molecular interactions: how hashtag#vascular and immune cells communicate, how inflammation drives recurrence, and how molecular signatures translate into clinical outcomes.
As we enter a new era of cardiovascular and neurovascular medicine, integrating molecular diagnostics + AI + spatial imaging isn’t just exciting science – it’s how we’ll prevent the next stroke (or maybe someday any stroke) before it happens.
If you’re working at this intersection, or building translational tools that turn biology into actionable data, let’s connect. This is where the next generation of precision care begins.”

Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS